Skip to main content
Clinical Trials/NCT05463198
NCT05463198
Completed
Not Applicable

Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600

Zynex Monitoring Solutions4 sites in 1 country351 target enrollmentSeptember 14, 2022
ConditionsFluid Loss

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fluid Loss
Sponsor
Zynex Monitoring Solutions
Enrollment
351
Locations
4
Primary Endpoint
Change in the Relative Index (RI) After Minor Blood Loss (e.g., 500mL)
Status
Completed
Last Updated
last year

Overview

Brief Summary

The study is a prospective, non-randomized, non-blinded, non-significant risk, multi-center study enrolling up to 500 healthy adult subjects consented to undergo a whole blood donation procedure. The study will involve enrolling subjects that will undergo blood donation wearing the study device (CM-1600 Device) and capture study-required physiological parameters pre-, during, and post-donation.

Registry
clinicaltrials.gov
Start Date
September 14, 2022
End Date
May 26, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Zynex Monitoring Solutions
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Ability to provide written consent
  • Ability and willingness to comply with the study procedures and duration requirements
  • 18 years of age or older
  • Consented and eligible to undergo a single unit whole blood donation

Exclusion Criteria

  • Females who are pregnant or breastfeeding
  • Undergone an amputation of any upper extremity
  • Diagnosed with dextrocardia
  • Subjects who have a pacemaker
  • Subjects with body hair density which prevents adequate application of device electrodes

Outcomes

Primary Outcomes

Change in the Relative Index (RI) After Minor Blood Loss (e.g., 500mL)

Time Frame: Recovery period following donation (10 minutes)

The objective of this study is to determine if manual blood loss of up to 500mL of blood can be identified using the non-invasive Zynex CM-1600. This will be measured by determining the percent change in Relative Index (RI) before and after the Blood Draw. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set minimum or maximum, where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.

Study Sites (4)

Loading locations...

Similar Trials